STAAR Surgical Company (STAA) News

Form 4 - Statement of changes in beneficial ownership of securities

STAAR Surgical to Participate in BTIG Ophthalmology Day

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO...

STAAR Surgical to Participate in Stephens Annual Investment Conference (NASH2024)

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO...

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

STAAR Surgical™ and Lucy Bronze, MBE See Eye to Eye on Vision Correction

STAAR Surgical™ and Lucy Bronze, MBE See Eye to Eye on Vision Correction PR Newswire LONDON, Nov. 4, 2024...

Form 8-K/A - Current report: [Amend]

CORRECTING and REPLACING STAAR Surgical Reports Third Quarter 2024 Results

Net Sales Up 10% to $88.6 Million Driven by Growth in All Regions Americas Up 14%, EMEA Up 12% and APAC Up 9% Market Building Initiatives Drive...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

STAAR Surgical Reports Third Quarter 2024 Results

Net Sales Up 10% to $88.6 Million Driven by Growth in All Regions Americas Up 14%, EMEA Up 12% and APAC Up 9% Market Building Initiatives Drive...

STAAR Surgical to Report Third Quarter Results on October 30, 2024

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO...

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

STAAR Surgical Experience Center Expands to Meet Growing Surgeon Demand

State-of-the-Art Facility Elevates Ophthalmic Education, Empowering Surgeons and Practitioners to Lead the Future of Vision Correction Myopia in...

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities